Fitabeo Therapeutics

Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company founded in 2022 in the United Kingdom. The company's slogan, "Innovating to Enhance Quality of Life," reflects its focus on developing and commercializing a differentiated portfolio of innovative medicines. Fitabeo Therapeutics operates within the biotechnology, healthcare, and life sciences industries, with a commitment to addressing indications where existing treatments are inadequate for the target population. The company differentiates itself by deploying breakthrough technologies to develop medicines that enable patient autonomy, decentralize patient care, and provide superior health outcomes. As of now, specific details regarding the last investment and investors have not been publicly disclosed.